Psychemedics Corporation – NASDAQ:PMD

Psychemedics stock price today

$2.67
Financial Health
0
1
2
3
4
5
6
7
8
9

Psychemedics stock price monthly change

+12.66%
month

Psychemedics stock price quarterly change

+12.66%
quarter

Psychemedics stock price yearly change

-7.61%
year

Psychemedics key metrics

Market Cap
15.73M
Enterprise value
15.51M
P/E
-3.36
EV/Sales
0.71
EV/EBITDA
-11.64
Price/Sales
0.69
Price/Book
2.38
PEG ratio
0.22
EPS
-0.77
Revenue
21.59M
EBITDA
-1.33M
Income
-4.45M
Revenue Q/Q
-8.56%
Revenue Y/Y
-12.17%
Profit margin
-20.64%
Oper. margin
-13.7%
Gross margin
38.57%
EBIT margin
-13.7%
EBITDA margin
-6.17%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Psychemedics stock price history

Psychemedics stock forecast

Psychemedics financial statements

Psychemedics Corporation (NASDAQ:PMD): Profit margin
Jun 2023 5.53M -726K -13.11%
Sep 2023 5.70M -2.09M -36.8%
Dec 2023 4.99M -945K -18.91%
Mar 2024 5.35M -688K -12.84%
2.71%
Yield TTM
Psychemedics Corporation (NASDAQ:PMD): Payout ratio
Payout ratio 0%
Psychemedics Corporation (NASDAQ:PMD): Dividend Yield
2019 7.87%
2020 3.53%
2021 0.72%
2022 4.3%
2023 4.7%
Psychemedics Corporation (NASDAQ:PMD): Debt to assets
Jun 2023 16386000 7.25M 44.3%
Sep 2023 14104000 6.67M 47.33%
Dec 2023 13270000 6.59M 49.72%
Mar 2024 11152000 4.87M 43.68%
Psychemedics Corporation (NASDAQ:PMD): Cash Flow
Jun 2023 -959K -48K -928K
Sep 2023 -958K -43K -74K
Dec 2023 662K 5K -73K
Mar 2024 -473K 5K -75K

Psychemedics alternative data

Psychemedics Corporation (NASDAQ:PMD): Employee count
Aug 2023 133
Sep 2023 133
Oct 2023 133
Nov 2023 133
Dec 2023 133
Jan 2024 133
Feb 2024 133
Mar 2024 133
Apr 2024 133
May 2024 116
Jun 2024 116
Jul 2024 116

Psychemedics other data

9.08% -15.96%
of PMD is owned by hedge funds
510.75K -901.04K
shares is hold by hedge funds

Psychemedics Corporation (NASDAQ:PMD): Insider trades (number of shares)
Period Buy Sel
Dec 2024 1409712 0
Transaction Date Insider Security Shares Price per share Total value Source
Purchase
KAMIN PETER director, 10 percent owner:
Common Stock, $0.005 Par Value 1,409,712 $2.35 $3,312,823
Sale
DOUCOT CHARLES M officer: Executiv.. Common Stock, $.005 Par Value 12,700 $4.66 $59,182
Purchase
SCHAFFER MICHAEL I officer: VP of La.. Common Stock, $.005 Par Value 100 $4.95 $495
Purchase
KAMIN PETER 10 percent owner
Common Stock 1,800 $6.72 $12,096
Purchase
KAMIN PETER 10 percent owner
Common Stock 3,808 $6.72 $25,590
Purchase
KAMIN PETER 10 percent owner
Common Stock 1,950 $6.72 $13,104
Purchase
KAMIN PETER 10 percent owner
Common Stock 8,100 $6.72 $54,432
Purchase
KAMIN PETER 10 percent owner
Common Stock 627 $6.52 $4,088
Purchase
KAMIN PETER 10 percent owner
Common Stock 15,152 $6.52 $98,791
Purchase
KAMIN PETER 10 percent owner
Common Stock 11,706 $6.52 $76,323
Patent
Application
Filling date: 21 Oct 2021 Issue date: 21 Apr 2022
Application
Filling date: 13 Sep 2019 Issue date: 18 Feb 2021
Monday, 2 December 2024
globenewswire.com
Tuesday, 12 November 2024
globenewswire.com
Thursday, 26 September 2024
globenewswire.com
Tuesday, 13 August 2024
globenewswire.com
Monday, 12 August 2024
globenewswire.com
Friday, 21 June 2024
globenewswire.com
Tuesday, 14 May 2024
globenewswire.com
Thursday, 28 March 2024
globenewswire.com
Thursday, 21 March 2024
globenewswire.com
Monday, 25 April 2022
Seeking Alpha
Tuesday, 7 December 2021
Seeking Alpha
Thursday, 18 November 2021
Seeking Alpha
Monday, 18 October 2021
Seeking Alpha
  • What's the price of Psychemedics stock today?

    One share of Psychemedics stock can currently be purchased for approximately $2.67.

  • When is Psychemedics's next earnings date?

    Unfortunately, Psychemedics's (PMD) next earnings date is currently unknown.

  • Does Psychemedics pay dividends?

    Yes, Psychemedics pays dividends and its trailing 12-month yield is 2.71% with 0% payout ratio. The last Psychemedics stock dividend of $0.05 was paid on 30 Dec 2021.

  • How much money does Psychemedics make?

    Psychemedics has a market capitalization of 15.73M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 12.45% to 22.1M US dollars.

  • What is Psychemedics's stock symbol?

    Psychemedics Corporation is traded on the NASDAQ under the ticker symbol "PMD".

  • What is Psychemedics's primary industry?

    Company operates in the Healthcare sector and Medical - Diagnostics & Research industry.

  • How do i buy shares of Psychemedics?

    Shares of Psychemedics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Psychemedics's key executives?

    Psychemedics's management team includes the following people:

    • Mr. Raymond C. Kubacki Chairman, Chief Executive Officer & Pres(age: 80, pay: $525,800)
    • Mr. Charles M. Doucot IV Executive Vice President(age: 59, pay: $316,520)
    • Dr. Michael I. Schaffer Ph.D. Vice President of Laboratory Operations(age: 80, pay: $282,700)
  • How many employees does Psychemedics have?

    As Jul 2024, Psychemedics employs 116 workers, which is 13% less then previous quarter.

  • When Psychemedics went public?

    Psychemedics Corporation is publicly traded company for more then 38 years since IPO on 22 Jan 1987.

  • What is Psychemedics's official website?

    The official website for Psychemedics is psychemedics.com.

  • Where are Psychemedics's headquarters?

    Psychemedics is headquartered at 289 Great Road, Acton, MA.

  • How can i contact Psychemedics?

    Psychemedics's mailing address is 289 Great Road, Acton, MA and company can be reached via phone at 978 206 8220.

Psychemedics company profile:

Psychemedics Corporation

psychemedics.com
Exchange:

NASDAQ

Full time employees:

116

Industry:

Medical - Diagnostics & Research

Sector:

Healthcare

Psychemedics Corporation provides testing services for the detection of drugs of abuse through the analysis of hair samples in the United States, Brazil, and internationally. The company offers screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, and PCP; amphetamines, including ecstasy, eve, and Adderall; opiates, such as heroin, hydrocodone, hydromorphone, oxycodone, oxymorphone, and codeine; synthetic cannabinoids comprising K2, Spice, and Blaze; benzodiazepines consisting of Xanax, Valium, and Ativan; and nicotine and Fentanyl. Its testing results provide quantitative information that could indicate the approximate amount of drug ingested, as well as historical data that could show a pattern of individual drug use over a longer period-of-time. The company offers its services to employers for applicant and employee testing; and treatment professionals, law enforcement agencies, school administrators, and parents concerned about their children's drug use. Psychemedics Corporation was incorporated in 1986 and is headquartered in Acton, Massachusetts.

289 Great Road
Acton, MA 01720

CIK: 0000806517
ISIN: US7443752057
CUSIP: 744375205